the current state-of-the-art in mf and pv therapy and future outlooks
Published 1 year ago • 144 plays • Length 2:16Download video MP4
Download video MP3
Similar videos
-
3:08
welcome to the video journal of hematology & hematological oncology 🎥🩸
-
2:01
the evolution of bcl2 inhibition in cll
-
1:35
novel mutations in pv & the importance of understanding their role in disease initiation
-
2:06
thromboembolic event rates in patients with pv: a real-world analysis
-
1:56
ongoing and future trials in mpn-ap/bp
-
1:27
current diagnostic modalities for the identification of ptld
-
2:03
an update on the phase ii/iii imerge trial of imetelstat in lr-mds
-
10:56
identifying and communicating your polycythemia vera (pv) symptoms
-
4:36
being marilyn…with myelofibrosis—an mf journey
-
1:46:07
hematology lecture
-
1:13
molecular mrd as a prognostic marker for aml patients with mutated cebpa
-
1:34
captivate trial: 5.5yr follow-up of the fixed-duration cohort
-
2:48
the promise of pyruvate kinase activators, such as mitapivat, for treating scd and thalassemia
-
3:10
novel aml treament approaches
-
5:06
considerations for drug development in hematological oncology
-
3:40
master class in transplantation and hematology: highlights
-
1:20
to jaki or not to jaki - treating early mf
-
9:25
mgus diagnosis: a step-by-step approach
-
3:50
changing clinical trial endpoints in mpns & the link between hematopoietic fitness and outcomes
-
5:18
upfront treatment in transplant candidates
-
1:18
updates in the treatment of r/r lbcl: promising novel agents in the pipeline